OKX ICE has filed for regulatory approval to offer 24-hour, seven-day-a-week tokenized trading across 60 U.S.-listed stocks, marking a bold push into digital asset markets. The move signals growing appetite among crypto-native
Amy Niles, chief mission officer at the Patient Advocate Foundation, formerly known as the PAN Foundation, has outlined her vision for patient access reform in 2026. Niles warns that while several healthcare
More
The growing wave of copyright litigation against artificial intelligence developers is raising serious concerns about the long-term accessibility of AI tools for businesses and consumers. Lawsuits filed by authors, publishers, visual artists,
More
The legal profession measures performance in hours, but those numbers rarely reveal whether a young lawyer is building something that will last. A firm will track assignments, deadlines, collections, and write-offs, and
More
Global equity markets advanced on Friday as crude oil prices held below the $90-per-barrel threshold, offering some relief to investors watching energy costs closely. The softer oil price environment helped ease inflationary
More
London’s benchmark index retreated to its lowest level in two weeks as a downgraded outlook from copper mining giant Antofagasta dragged on sentiment across the broader market. Antofagasta, listed on the London
More
Abbott (NYSE: ABT) and the Big Ten Conference are relaunching their “We Give Blood” campaign as the United States grapples with a severe national blood shortage. The American Red Cross has declared
More
Chicago has joined a growing number of cities pushing back against the rapid expansion of data centres, with Mayor Brandon Johnson signing a sweeping executive order on August 11, 2026. The order,
More
Texas Attorney General Ken Paxton faced an uncomfortable moment during a tele-town hall this week, held as part of his ongoing Senate campaign. A caller cut straight to the point, skipping any
More
Lettuce prices suffered their steepest monthly fall on record in July as a multistate cyclospora outbreak pushed diners to avoid the leafy green entirely. Prices for the vegetable dropped 16.4% from June,
More
Eli Lilly (LLY) delivered another extraordinary quarter of growth, posting a 48% year-over-year sales increase despite a slower-than-expected launch for its oral obesity drug Foundayo. Lilly reported Foundayo sales of $98 million
More